1. Home
  2. COEP vs VTSI Comparison

COEP vs VTSI Comparison

Compare COEP & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • VTSI
  • Stock Information
  • Founded
  • COEP 2017
  • VTSI 1993
  • Country
  • COEP United States
  • VTSI United States
  • Employees
  • COEP N/A
  • VTSI N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • COEP Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • COEP 62.4M
  • VTSI 60.6M
  • IPO Year
  • COEP N/A
  • VTSI N/A
  • Fundamental
  • Price
  • COEP $12.96
  • VTSI $5.69
  • Analyst Decision
  • COEP
  • VTSI Strong Buy
  • Analyst Count
  • COEP 0
  • VTSI 1
  • Target Price
  • COEP N/A
  • VTSI $7.00
  • AVG Volume (30 Days)
  • COEP 45.5K
  • VTSI 42.2K
  • Earning Date
  • COEP 11-12-2025
  • VTSI 11-11-2025
  • Dividend Yield
  • COEP N/A
  • VTSI N/A
  • EPS Growth
  • COEP N/A
  • VTSI N/A
  • EPS
  • COEP N/A
  • VTSI 0.10
  • Revenue
  • COEP $263,555.00
  • VTSI $27,068,543.00
  • Revenue This Year
  • COEP N/A
  • VTSI $10.31
  • Revenue Next Year
  • COEP N/A
  • VTSI $12.71
  • P/E Ratio
  • COEP N/A
  • VTSI $55.84
  • Revenue Growth
  • COEP N/A
  • VTSI N/A
  • 52 Week Low
  • COEP $2.31
  • VTSI $3.57
  • 52 Week High
  • COEP $14.70
  • VTSI $8.53
  • Technical
  • Relative Strength Index (RSI)
  • COEP 54.10
  • VTSI 45.59
  • Support Level
  • COEP $12.09
  • VTSI $5.51
  • Resistance Level
  • COEP $13.53
  • VTSI $5.79
  • Average True Range (ATR)
  • COEP 0.74
  • VTSI 0.22
  • MACD
  • COEP -0.12
  • VTSI 0.00
  • Stochastic Oscillator
  • COEP 56.55
  • VTSI 35.59

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: